Details

Expanding the reactive chemistry toolbox – warhead screening for covalent butyrylcholinesterase inhibitors
ID Meden, Anže (Author), ID Brazzolotto, Xavier (Author), ID Dias, José (Author), ID Stojan, Jure (Author), ID Knez, Damijan (Author), ID Gobec, Stanislav (Author)

.pdfPDF - Presentation file, Download (3,54 MB)
MD5: C21F3AA0C2E550E36873308A0CFDB757
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S0009279725004715 This link opens in a new window

Abstract
Many covalent inhibitors of butyryl- and acetylcholinesterase, typically featuring electrophilic carbamoyl, phosphonyl, and sulfonyl groups, were reported in the literature. In this study, we screened these and several other electrophilic moieties for covalent cholinesterase inhibition. The electrophilic warheads were either installed at different positions on a reversible, selective human butyrylcholinesterase inhibitor scaffold or featured as small molecular weight, fragment-sized compounds. Time-dependency of the enzyme inhibition served as an indicator of covalent binding. The 7-indolyl substitution pattern proved optimal for generating time-dependent inhibitors, and carbamate chemotype produced most of the time-dependent hit compounds. Interestingly, the carbamates' reactivity was strongly influenced by their leaving groups’ nucleofugality and not by steric hindrance, as sufficiently acidic leaving groups (pKa <10) enabled carbamoylation of the catalytic serine. Notably, an exception to this rule of a thumb was found in a series of chalcogen carbachol analogues. The gathered insights highlight some key structure–reactivity relationships for covalent hBChE inhibitors and may assist in development of novel serine hydrolase inhibitors.

Language:English
Keywords:cholinesterase inhibitors, warhead, irreversible inhibition, butyrylcholinesterase, carbamate
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:26 str.
Numbering:Vol. 423, art. 111841
PID:20.500.12556/RUL-179045 This link opens in a new window
UDC:615.4:54:616.894
ISSN on article:1872-7786
DOI:10.1016/j.cbi.2025.111841 This link opens in a new window
COBISS.SI-ID:260611587 This link opens in a new window
Publication date in RUL:04.02.2026
Views:424
Downloads:245
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Chemico-biological interactions
Publisher:Elsevier
ISSN:1872-7786
COBISS.SI-ID:23211013 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:zaviralci holinesteraze, bojna glava, ireverzibilna inhibicija, butirilholinesteraza, karbamat, farmacevtska kemija, analizna kemija

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0012
Name:Molekulske simulacije, bioinformatika in načrtovanje zdravilnih učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young researchers

Funder:France, Ministry of Armed Forces
Project number:NBC-5-C-4210

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back